
|Articles|August 23, 2022
Figures for Interest Grows in Treatment of Mood Disorders by Classic Psychedelics
This is the extra table for "Interest Grows in Treatment of Mood Disorders by Classic Psychedelics."
Advertisement
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia
2
Cobenfy for Treatment of Schizophrenia Now Approved in China
3
Programs for ST-905 and ST-905 for Schizophrenia and Depression Launched by Syremis Therapeutics
4
Latest Alzheimer Disease Data: Reports from CTAD 2025
5

















